Related Experiment Video
Updated: Aug 21, 2026

Scanning Skeletal Remains for Bone Mineral Density in Forensic Contexts
Published on: January 29, 2018
Short stature in beta-thalassemia minor subjects
Mehran Karimi1, Hamd-Allah Karamifar
1Hematology Research Center, Department of Pediatrics, Shiraz University of Medical Sciences, Shiraz, Iran. karimi@sums.ac.ir
Insights
Short stature is more common in children with beta-thalassemia minor, a condition affecting hemoglobin synthesis. This study investigated growth in these children, finding a significant link between thalassemia minor and short stature.
Area of Science:
- Pediatrics
- Genetics
- Hematology
Background:
- Beta-thalassemia major patients exhibit growth disturbances.
- Short stature in beta-thalassemia minor, a milder form of hemoglobin synthesis defect, remains understudied.
Purpose of the Study:
- To investigate the prevalence of short stature in children with beta-thalassemia minor.
- To compare growth parameters in beta-thalassemia minor subjects with a healthy control group.
Main Methods:
- A cross-sectional study measured heights of 100 children (2-18 years) with thalassemia minor and their parents.
- Subjects with height below the 3rd percentile underwent extensive clinical and paraclinical evaluations.
- A control group of 100 healthy children was matched for demographic characteristics.
Main Results:
- The mean age of subjects was 6.62 years.
- Short stature was observed in 27% of thalassemia minor patients.
- All paraclinical data, except for hemoglobin levels, were within normal limits.
Conclusions:
- Short stature is significantly more prevalent in beta-thalassemia minor subjects compared to controls.
- Beta-thalassemia minor is identified as a potential cause of short stature in children.
Background:
Numerous disturbances in growth and development have been observed and demonstrated in homozygote beta-thalassemia patients. However, short stature in thalassemia minor subjects, who have a minor defect in hemoglobin chain synthesis, has not yet been studied.
Material/Methods:
In this cross-sectional study, the heights of 100 thalassemia minor subjects in the age group of 2-18 years and their parents were measured and analyzed. If the subject were in the 3-10 percentile range of height based on standardized sex and age curves, several follow-ups with complete history and physical examinations for a period of one year were preformed. If the healthy carrier's height was below the 3rd percentile, history, physical examination, and paraclinical examinations, including BUN, creatinine, electrolytes, serum alkaline phosphatase, thyroid function tests, growth hormone and cortisol levels, arterial blood gas, radiography of the left hand and wrist, etc, were also checked. One hundred healthy children were randomly chosen as a control group and matched for demographic characteristics with our healthy carrier subjects.
Results:
Mean +/- standard deviation for the age of our subjects was 6.62+/-3.63 years old. Twenty-seven (27%) of the patients had short stature. Except for hemoglobin (with a mean of 11.5 g/l), all other paraclinical data were normal.
Conclusions:
We concluded that short stature was significantly more prevalent in the healthy beta thalassemia minor subjects than in the control group (p<0.001). Therefore, thalassemia minor can cause short stature.
Related Concept Videos
Nature and Nurture
Polygenic Traits
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
